# NIH Awards Salimetrics SBIR Grant

On November 5, 2026, the National Institutes of Health awarded Salimetrics, LLC an SBIR Phase I grant under funding opportunity RFA-MD-24-006 to assess whether insulin can be measured in dried saliva spots. The Phase I project includes analytical and feasibility studies and engagement with community partners, exploring a collection method intended to reduce logistical barriers to metabolic health research. The award amount was not disclosed, and the findings may inform subsequent research and development.

- The award supports early-stage evaluation of a diagnostic research approach; it does not establish that the method is validated or ready for clinical use.
- For biomedical research and diagnostic firms, this award illustrates an NIH SBIR pathway for assessing feasibility and developing evidence for research tools.
- Companies pursuing related research can use the announced scope and funding opportunity identifier, RFA-MD-24-006, to understand the project’s focus; the signal does not identify an open solicitation or provide a submission deadline.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Grants & Funding
**Published:** November 05, 2026

### Government Entities
- National Institutes of Health (NIH)

### Vendors
- Salimetrics, LLC (awardee)

### Key Quotes
> This award gives us the opportunity to evaluate a promising approach to metabolic health assessment while working with partners who understand the needs of underserved communities. Our immediate focus is on generating the evidence needed to guide responsible development and determine its potential value in research and, ultimately, health care.
> — Steve Granger, Chief Scientific Officer, Salimetrics

### Sources
- [
  Salimetrics Awarded NIH SBIR Phase I Grant to Advance Accessible Metabolic Health Assessment
  
](https://www.einpresswire.com/article/954198873/salimetrics-awarded-nih-sbir-phase-i-grant-to-advance-accessible-metabolic-health-assessment) - EIN Presswire